Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Nom du journal : J Clin Oncol
Année : 2023
Volume : 41
Page de départ : 4768-4778
